暗盘异动丨瑞博生物暗盘大涨近40%，一手赚4606港元

Group 1 - The core viewpoint of the article is that Rebio Pharmaceuticals-B (6938.HK) is set to be listed on the Hong Kong Stock Exchange tomorrow, with significant interest shown in pre-listing trading [1] - In dark pool trading today, the stock price surged nearly 40%, reaching HKD 81, indicating strong market demand [1] - Each trading lot consists of 200 shares, allowing investors to potentially earn HKD 4,606 per lot, highlighting the lucrative opportunity for early investors [1] Group 2 - Rebio Pharmaceuticals specializes in the research and development of small nucleic acid drugs, particularly focusing on siRNA therapies, positioning itself as a pioneer in this field since its inception in 2007 [1]